Calculate your body mass index (BMI)

Weight

Feet

Inches

Your BMI

Back to list

Healthy Volunteers 245922


Study Dates: 15/9/19 - 28/2/21

Trial Number

245922

Group

●  Healthy Volunteer
●  Smoking (No)

Compensation

Up to: $3,010

Gender

Male, Female, Non-Smoker

Age

18 to 55 years

BMI

18.0 – 30.0 kg/m2 (inclusive)

Additional Information

The study consist of 11 nights in house and 1 follow up

£50 will be paid for the screening visit


Cohort 7 admission 9th February to 20th February and Follow visit up 26th February

Cohort 8 admission 11th to 22nd February and Follow up visit 28th February




Details

The new medicine tested in this study is a compound called MD1003 (referred to as the “study drug” throughout the remainder of this document). The Sponsor is developing the study drug primarily for the treatment of primary and secondary progressive multiple sclerosis (MS).

The main purpose of the study is to test the effect of 1200 mg study drug on the electrical activity of the heart when compared with moxifloxacin and placebo. For this reason, certain measurement categories in the ECG will be analysed.

You will receive the study drug (MD1003) or its placebo in the form of a capsule (12 capsules per day from Day 1 to Day 8) and Moxifloxacin or its placebo in the form of a capsule (1 capsule per day on Days 1 and 9) which you will swallow with a glass of water

This is not a first into human study